CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B� HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study-Reference-Cited by-同舟云学术

CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B� HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study

Published:2004-11 Issue:6 Volume:24 Page:693-701
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

COOPER C.L.,DAVIS H.L.,MORRIS M.L.,EFLER S.M.,ADHAMI M. AL,KRIEG A.M.,CAMERON D.W.,HEATHCOTE J.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10875-004-6244-3.pdf

Reference25 articles.

1. Lee WM: Hepatitis B virus infection. N Engl J Med337:1733?1745, 1997

2. Maddrey WC: Hepatitis B: An important public health issue. J Med Virol61:362?366, 2000

3. Hepatitis B Vaccination?United States, 1982?2002, MMWR Morb Mortal Wkly Rep51:549?552, 563, 2002

4. Chisari FV: Cytotoxic T cells and viral hepatitis. J Clin Invest99:1472?1477, 1997

5. Rehermann B: Intrahepatic T cells in hepatitis B: Viral control versus liver cell injury. J Exp Med191:1263?1268, 2000

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions;Cell & Bioscience;2024-02-17

2. Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice;Vaccine;2023-11

3. Vaccine adjuvants: mechanisms and platforms;Signal Transduction and Targeted Therapy;2023-07-19

4. Identification of novel T-cell epitopes on monkeypox virus and development of multi-epitopes vaccine using immunoinformatics approaches;Journal of Biomolecular Structure and Dynamics;2023-06-24

5. A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine;Vaccine;2023-04